Complete Hearing Recovery in Sudden Sensorineural Hearing Loss with Type 2 Diabetes Mellitus and Steroid-Aggravated Hyperglycaemia: A Case Report

Authors

  • Ni Made Pasmiati Setyaningsih Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universitas Udayana / Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali, Indonesia
  • Ni Putu Oktaviani Rinika Pranitasari Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universitas Udayana / Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali, Indonesia https://orcid.org/0000-0001-9121-7173

DOI:

https://doi.org/10.38035/ijphs.v4i3.2267

Keywords:

Sudden Sensorineural Hearing Loss, Type 2 Diabetes Mellitus, Corticosteroid, Hyperglycaemia, Hyperbaric Oxygen Therapy

Abstract

Sudden sensorineural hearing loss (SSNHL) is an otologic emergency defined as a hearing decline of at least 30 dB across three contiguous frequencies within 72 hours. Type 2 diabetes mellitus (T2DM) is a recognised risk factor and a predictor of poorer recovery, yet high-dose corticosteroid remains first-line therapy, creating a therapeutic dilemma. A 56-year-old woman with severely uncontrolled T2DM (HbA1c above 14%) and hypercholesterolaemia presented two days after sudden right-sided hearing loss. Audiometry confirmed moderate-to-severe SSNHL of the right ear. She received intravenous methylprednisolone tapered over 15 days, five sessions of hyperbaric oxygen therapy, statin therapy, and endocrinology-guided basal-bolus insulin. Hearing thresholds returned to normal by treatment day seven and remained normal at day twelve, meeting complete recovery by modified Siegel's criteria. Capillary glucose exceeded the glucometer limit of 500 mg/dL on four occasions, highest measured value 496 mg/dL. Hyperglycaemia was managed by insulin intensification without reducing or discontinuing corticosteroid, and no clinical hyperglycaemic crisis was documented. Causal attribution of recovery to treatment cannot be established from a single case because several favourable prognostic factors were present. Full-dose corticosteroid appears feasible in severely uncontrolled T2DM when structured glucose monitoring and endocrinology collaboration are available.

References

Alter, I. L., Hamiter, M., Han, J., Leu, C.-S., Usseglio, J., & Lalwani, A. K. (2026). Hyperbaric oxygen and sudden sensorineural hearing loss: A systematic review and meta-analysis. The Laryngoscope, 136(1), 91–101. https://doi.org/10.1002/lary.32472

Capaccio, P., Pignataro, L., Gaini, L. M., Sigismund, P. E., Novembrino, C., & De Giuseppe, R. (2012). Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology, 269(2), 449–453. https://doi.org/10.1007/s00405-011-1671-2

Chandrasekhar, S. S., Tsai Do, B. S., Schwartz, S. R., Bontempo, L. J., Faucett, E. A., Finestone, S. A., Hollingsworth, D. B., Kelley, D. M., Kmucha, S. T., Moonis, G., Poling, G. L., Roberts, J. K., Stachler, R. J., Zeitler, D. M., Corrigan, M. D., Nnacheta, L. C., & Satterfield, L. (2019). Clinical practice guideline: Sudden hearing loss (update). Otolaryngology-Head and Neck Surgery, 161(1_suppl), S1–S45. https://doi.org/10.1177/0194599819859885

Chaushu, H., Ungar, O. J., Abu Eta, R., Handzel, O., Muhanna, N., & Oron, Y. (2023). Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: A systematic review and meta-analysis. Clinical Otolaryngology, 48(3), 395–402. https://doi.org/10.1111/coa.14036

Cheng, Y.-F., Chu, Y.-C., Tu, T.-Y., Shiao, A.-S., Wu, S.-L., & Liao, W.-H. (2018). Modified Siegel’s criteria for sudden sensorineural hearing loss: Reporting recovery outcomes with matched pretreatment hearing grades. Journal of the Chinese Medical Association, 81(11), 1008–1012. https://doi.org/10.1016/j.jcma.2018.03.012

Deng, Y., Chen, S., & Hu, J. (2023). Diabetes mellitus and hearing loss. Molecular Medicine, 29(1). https://doi.org/10.1186/s10020-023-00737-z

Diao, T., Ke, Y., Zhang, J., Jing, Y., & Ma, X. (2022). Correlation between the prognosis of sudden total deafness and the peripheral blood inflammation markers. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.927235

Ha, Y. R., Kim, D., Kim, S. S., Lee, J. M., Kim, S. H., & Yeo, S. G. (2024). Comparison of recovery rates of sudden sensorineural hearing loss by age group. Journal of Clinical Medicine, 13(16), 4937. https://doi.org/10.3390/jcm13164937

Helzner, E. P., & Contrera, K. J. (2016). Type 2 diabetes and hearing impairment. Current Diabetes Reports, 16(1), 3. https://doi.org/10.1007/s11892-015-0696-0

Joshua, T. G., Ayub, A., Wijesinghe, P., & Nunez, D. A. (2022). Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: A systematic review and meta-analysis. JAMA Otolaryngology-Head and Neck Surgery, 148(1), 5–11. https://doi.org/10.1001/jamaoto.2021.2685

Ju, Y. R., Park, H. S., Lee, M. Y., Jung, J. Y., & Choi, J. E. (2021). Clinical features and hearing outcomes of sudden sensorineural hearing loss in diabetic patients. Journal of Audiology and Otology, 25(1), 27–35. https://doi.org/10.7874/jao.2020.00262

Kang, J. W., Kim, M. G., Kim, S. S., Im, H. Il, Dong, S. H., & Kim, S. H. (2020). Neutrophil-lymphocyte ratio as a valuable prognostic marker in idiopathic sudden sensorineural hearing loss. Acta Oto-Laryngologica, 140(4), 307–313. https://doi.org/10.1080/00016489.2019.1705998

Karol, A. B., Viera, N., Ogyaadu, S. J., Brooks, D., Shah, N. A., Linker, A. S., Lam, D. W., Levy, C. J., & O’Malley, G. (2023). A novel algorithm for the management of inpatient COVID-19 glucocorticoid-induced hyperglycemia. Clinical Diabetes, 41(3), 378–385. https://doi.org/10.2337/cd22-0083

Ko, H. Y., Nam, H. J., & Kim, M. H. (2024). A nationwide population-based study for the recurrence and comorbidities in sudden sensorineural hearing loss. The Laryngoscope, 134(3), 1417–1425. https://doi.org/10.1002/lary.31024

Kuhn, M., Heman-Ackah, S. E., Shaikh, J. A., & Roehm, P. C. (2011). Sudden sensorineural hearing loss: A review of diagnosis, treatment, and prognosis. Trends in Amplification, 15(3), 91–105. https://doi.org/10.1177/1084713811408349

Lee, H. A., & Chung, J. H. (2024). Contemporary review of idiopathic sudden sensorineural hearing loss: Management and prognosis. Journal of Audiology and Otology, 28(1), 10–17. https://doi.org/10.7874/jao.2024.00024

Lee, J. W., Kim, H., Kong, S. K., Kim, J., Choi, S. W., & Oh, S. J. (2024). The effectiveness of salvage hyperbaric oxygen therapy following combined steroid therapy for refractory sudden sensorineural hearing loss. Annals of Otology, Rhinology and Laryngology, 133(4), 400–405. https://doi.org/10.1177/00034894231222692

Lin, S.-W., Lin, Y.-S., Weng, S.-F., & Chou, C.-W. (2012). Risk of developing sudden sensorineural hearing loss in diabetic patients: A population-based cohort study. Otology & Neurotology, 33(9), 1482–1488. https://doi.org/10.1097/MAO.0b013e318271397a

Lin, W., Xiong, G., Yan, K., Yu, W., Xie, X., & Xiang, Z. (2022). Clinical features and influencing factors for the prognosis of patients with sudden deafness. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.905069

Lundholm, M. D., & Morey-Vargas, O. L. (2023). Inpatient glycemic management in noncritically ill patients: Updated guidelines. Cleveland Clinic Journal of Medicine, 90(10), 615–618. https://doi.org/10.3949/ccjm.90a.23049

Niedermeyer, H. P., Zahneisen, G., Luppa, P., Busch, R., & Arnold, W. (2003). Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiology and Neuro-Otology, 8(6), 316–321. https://doi.org/10.1159/000073516

Prince, A. D. P., & Stucken, E. Z. (2021). Sudden sensorineural hearing loss: A diagnostic and therapeutic emergency. Journal of the American Board of Family Medicine, 34(1), 216–223. https://doi.org/10.3122/jabfm.2021.01.200199

Rauch, S. D., Halpin, C. F., Antonelli, P. J., Babu, S., Carey, J. P., Gantz, B. J., Goebel, J. A., Hammerschlag, P. E., Harris, J. P., Isaacson, B., Lee, D., Linstrom, C. J., Parnes, L. S., Shi, H., Slattery, W. H., Telian, S. A., Vrabec, J. T., & Reda, D. J. (2011). Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: A randomized trial. JAMA, 305(20), 2071–2079. https://doi.org/10.1001/jama.2011.679

Rhee, T.-M., Hwang, D., Lee, J.-S., Park, J., & Lee, J. M. (2018). Addition of hyperbaric oxygen therapy vs medical therapy alone for idiopathic sudden sensorineural hearing loss: A systematic review and meta-analysis. JAMA Otolaryngology-Head and Neck Surgery, 144(12), 1153–1161. https://doi.org/10.1001/jamaoto.2018.2133

Rozbicki, P., Usowski, J., Krzywdzinska, S., Jurkiewicz, D., & Siewiera, J. (2024). Assessing the effectiveness of different hyperbaric oxygen treatment methods in patients with sudden sensorineural hearing loss. Audiology Research, 14(2), 333–341. https://doi.org/10.3390/audiolres14020029

Shen, Y., Zheng, Z., Xiao, L., Liu, C., Guo, J., & Chen, Z. (2021). Association of glycosylated hemoglobin A1c level with sudden sensorineural hearing loss: A prospective study. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.763021

Singh, A., & Kumar Irugu, D. V. P. (2020). Sudden sensorineural hearing loss: A contemporary review of management issues. Journal of Otology, 15(2), 67–73. https://doi.org/10.1016/j.joto.2019.07.001

Tripathi, P., & Deshmukh, P. (2022). Sudden sensorineural hearing loss: A review. Cureus, 14(9). https://doi.org/10.7759/cureus.29458

Tsuzuki, N., & Wasano, K. (2024). Idiopathic sudden sensorineural hearing loss: A review focused on the contribution of vascular pathologies. Auris Nasus Larynx, 51(4), 747–754. https://doi.org/10.1016/j.anl.2024.05.009

Yang, W., Li, X., Zhong, J., Mei, X., Liu, H., & Yang, L. (2020). Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: Proposed study protocol for a prospective, randomized superiority trial. Trials, 21(1), 132. https://doi.org/10.1186/s13063-020-4077-x

Downloads

Published

2026-08-10

Issue

Vol. 4 No. 3 (2026): International Journal of Psychology and Health Science (July - September 2026)

Section

Articles

License

Copyright (c) 2026 Ni Made Pasmiati Setyaningsih, Ni Putu Oktaviani Rinika Pranitasari

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish their manuscripts in this journal agree to the following conditions:

  1. The copyright on each article belongs to the author(s).
  2. The author acknowledges that the International Journal of  Psycology and  Healt Science (IJPHS) has the right to be the first to publish with a Creative Commons Attribution 4.0 International license (Attribution 4.0 International (CC BY 4.0).
  3. Authors can submit articles separately, arrange for the non-exclusive distribution of manuscripts that have been published in this journal into other versions (e.g., sent to the author's institutional repository, publication into books, etc.), by acknowledging that the manuscript has been published for the first time in the IJPHS.